Oral Minoxidil for Hair Loss: 2024 Meta-Analysis Research Summary
This is a plain-language summary of the original published research. We do not add conclusions or opinions of our own. This is not medical advice — consult a certified healthcare practitioner before making any decision.
Original research published in Frontiers in Pharmacology, 2024
Oral Minoxidil for Hair Loss: 2024 Meta-Analysis Research Summary
Study conclusion
This study combined results from multiple studies of oral minoxidil (minoxidil taken as a tablet) for hair loss. Oral minoxidil significantly improved hair density and growth rate. The 1mg daily dose was shown to be safe with no serious adverse events reported.
Strength of evidence
Who it applies to
Who was studied
Adults with various types of hair loss including pattern hair loss, female pattern hair loss, and other forms of alopecia. Men and women. Studies used oral minoxidil doses ranging from 0.25mg to 5mg daily.
Who was NOT studied
People using topical minoxidil applied to the scalp. Children. People with hair loss conditions not covered by the included studies.
What to look for when shopping
Oral minoxidil is a prescription medication — not available over the counter. It is used off-label for hair loss; it is FDA-approved as a blood pressure medication, not specifically for hair loss. The 1mg daily dose showed a favourable safety profile in this review.
What research cannot help you decide
The optimal dose for your specific situation. How oral minoxidil compares to topical minoxidil for your hair loss type. Whether side effects (which include unwanted body hair growth and fluid retention) will affect you. These are questions for a prescribing doctor.
Key findings
- Oral minoxidil significantly improved hair density and growth rate across the included studies
- The 1mg daily dose was safe with no serious adverse events reported in the studies
- Side effects are dose-dependent — higher doses carry higher risk of unwanted body hair growth and fluid retention
- Oral minoxidil is used off-label for hair loss — it is not FDA-approved specifically for this use
- Results were seen across both male and female pattern hair loss in the included studies
What this study does not show
- 1.The optimal dose for different hair loss types. Evidence for doses above 1mg is more limited in this review.
- 2.How oral minoxidil compares directly to topical minoxidil in a head-to-head controlled trial.
- 3.Whether results last after stopping. Oral minoxidil, like topical minoxidil, likely requires ongoing use to maintain results.
- 4.Long-term safety beyond the study periods included in this review.
Limitations
- 1.Most included studies were retrospective — looking back at patient records rather than running prospective controlled trials. This increases risk of bias.
- 2.No placebo-controlled randomised trial was included as the primary data source.
- 3.Dose ranges varied widely across included studies, making it difficult to define an optimal dose.
- 4.Side effects including hypertrichosis and fluid retention are dose-dependent and not fully characterised at all doses.
Used in these articles
Links added as fact-checks and articles citing this study are published.